The role of mitogen-activated protein (MAP) kinase in breast cancer

Journal of Steroid Biochemistry and Molecular Biology

Volumn 80, Issue 2, 2002, Pages 239-256

  Santen, Richard J ^a   Song, Robert Xinde ^a   McPherson, Robert ^a   Kumar, Rakesh ^b   Adam, Liana ^b   Jeng, Meei Huey ^c   Yue, Wei ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c INDIANA UNIVERSITY   (United States)

Author keywords

Breast cancer; ERK 1 and 2; Estradiol hypersensitivity; MAP kinase

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; ALPHA (3,4 DIMETHOXYBENZYLIDENE) 2 PYRIDYLACETONITRILE; ANDROGEN; COMPACTIN; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR; FULVESTRANT; G PROTEIN COUPLED RECEPTOR; GROWTH FACTOR; MITOGEN ACTIVATED PROTEIN KINASE; N BENZYL 2 CYANO 3 (3,4 DIHYDROXYPHENYL)ACRYLAMIDE; N BUTYL 11 (3,17BETA DIHYDROXYESTRA 1,3,5(10) TRIEN 7ALPHA YL) N METHYLUNDECANAMIDE; OKADAIC ACID; PROGESTERONE; PROTEIN TYROSINE KINASE; TESTOSTERONE;

APOPTOSIS; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER CELL; CELL DEATH; CELL PROLIFERATION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME LOCALIZATION; HORMONAL REGULATION; HUMAN; NONHUMAN; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; TISSUE LEVEL;

BREAST NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GROWTH SUBSTANCES; HUMANS; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASES;

EID: 0036128068     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-0760(01)00189-3     Document Type: Article

References (125)

1. Cancer statistics, 2001
2. The Bcl-2 protein family: Arbiters of cell survival
3. Caspases: Enemies within
4. Mitochondria and apoptosis
5. A matter of life and cell death
6. Death receptors: Signaling and modulation
7. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery
8. Suppression of c-Myc-induced apoptosis by Ras signalling through PI(3)K and PKB
9. Defining a role for c-Myc in breast tumorigenesis
10. A Myc-induced apoptosis pathway surfaces
11. Apoptotic response to oncogenic stimuli: Cooperative and antagonistic interactions between c-myb and the growth suppressor p53
12. Activation of mitogen-activated protein kinase associated with prostate cancer progression
13. Tripping the switch fantastic: How a protein kinase cascade can convert graded inputs into switch-like outputs
14. Mitogen-activated protein (map) kinase pathways: Regulation and physiological functions
15. Routing MAP kinase cascades
16. Evolution of Shc functions from nematode to human
17. Ras activation of the Raf kinase: Tyrosine kinase recruitment of the MAP kinase cascade
18. Acetylcholine muscarinic receptor regulation of the Ras/Raf/MAP kinase pathway
19. Binding of urokinase-type plasminogen activator to its receptor in MCF-7 cells activates extracellular signal-regulated kinase 1 and 2 which is required for increased cellular motility
20. Arachidonic acid activates mitogen-activated protein (MAP) kinase-activated protein kinase 2 and mediates adhesion of a human breast carcinoma cell line to collagen type IV through a p38 MAP kinase-dependent pathway
21. Meaningful relationships: The regulation of the Ras/Raf/MEK/ERK pathway by protein interactions
22. Expanding roles for β-arrestins as scaffolds and adapters in GPCR signaling and trafficking
23. Protein kinase C α activates RAF-1 by direct phosphorylation
24. Requirement of Ras-GTP-Raf complexes for activation of Raf-1 by protein kinase C
25. Phosphatidylinositol 3-kinase regulates Raf-1 through PAK phosphorylation of serine 338
26. The protein kinase PAK-3 positively regulates Raf-1 activity through phosphorylation of serine 338
27. S338 phosphorylation of Raf-1 is independent of phosphatidylinositol 3-kinase and PAK-3
28. Phosphorylation and regulation of Raf by Akt (protein kinase B)
29. Phosphatidylinositol 3-kinase is required for integrin-stimulated Akt and Raf-1/mitogen-activated protein kinase pathway activation
30. Activation of mitochondrial Raf-1 is involved in the antiapoptotic effects of Akt
31. Synergistic effects of PI3k/Akt on abrogation of cytokine-dependency induced by oncogenic raf
32. Feedback regulation of Raf-1 and mitogen-activated protein kinase (MAP) kinase kinases 1 and 2 by MAP kinase phosphatase-1 (MKP-1)
33. Raf-1-associated protein phosphatase 2A as a positive regulator of kinase activation
34. MEK kinase activity is not necessary for Raf-1 function
35. B-Raf inhibits programmed cell death downstream of cytochrome C release from mitochondria by activating the MEK/ERK pathway
36. Interaction between the protein kinase B-Raf and the α-subunit of the 11S proteasome regulator
37. Serine and tyrosine phosphorylations cooperate in Raf-1, but not B-Raf activation
38. A different function for a critical tryptophan in c-Raf and Hck
39. Rap1 mediates sustained MAP kinase activation induced by nerve growth factor
40. Estrogen-induced activation of mitogen-activated protein kinase requires mobilization of intracellular calcium
41. Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase
42. pp90rsk1 regulates estrogen receptor-mediated transcription through phosphorylation of Ser-167
43. Phosphorylation of human progesterone receptors at serine-294 by mitogen-activated protein kinase signals their degradation by the 26S proteasome
44. Activation of Raf-1, MEK, and MAP kinase in prolactin responsive mammary cells
45. Activation of the Ras signalling pathway in human breast cancer cells overexpressing ERB-B-2
46. Inhibition of the MAP kinase cascade blocks heregulin-induced cell cycle progression in T-47D human breast cancer cells
47. Cripto enhances the tyrosine phosphorylation of Shc and activates mitogen-activated protein kinase (MAPK) in mammary epithelial cells
48. Urokinase-type plasminogen activator stimulates the Ras/extracellular signal-regulated kinase (ERK) signaling pathway and MCF-7 cell migration by a mechanism that requires focal adhesion kinase, SRC, and Shc. Rapid dissociation of GRB-2/Sps-Shc complex is associated with the transient phosphorylation of ERK in urokinase-treated cells
49. Binding of urokinase-type plasminogen activator to its receptor in MCF-7 cells activates extracellular signal-regulated kinase 1 and 2 which is required for increased cellular motility
50. The role of MAP kinase in TPA-mediated cell cycle arrest of human breast cancer cells
51. Involvement of extracellular signal-regulated kinase 2 and stress-activated protein kinase/Jun N-terminal kinase activation by transforming growth factor-β in the negative growth control of breast cancer cells
52. Interleukin 6 inhibits proliferation and, in cooperation with an epidermal growth factor receptor autocrine loop, increases migration of T47D breast cancer cells
53. Ras activation in human breast cancer
54. The mitogenic signaling pathway for fibroblast growth factor-2 involves the tyrosine phosphorylation of cyclin D2 in MCF-7 human breast cancer cells
55. Tumor-necrosis factor-α modulates mitogen-activated protein kinase activity of epidermal-growth-factor-stimulated MCF-7 breast cancer cells
56. The antiestrogen ICI 182780 inhibits proliferation of human breast cancer cells by interfering with multiple, sequential estrogen-regulated processes required for cell cycle completion
57. Estrogen induces early and timed activation of cyclin-dependent kinases 4, 5, and 6 and increases cyclin messenger ribonucleic acid expression in rat uterus
58. 17β-Estradiol overcomes a G1 block induced by HMG-CoA reductase inhibitors and fosters cell cycle progression without inducing ERK-1 and -2 MAP kinases activation
59. Stimulation of human breast cancer MCF-7 cells with estrogen prevents cell cycle arrest by HMG-CoA reductase inhibitors
60. 17β-Estradiol induces cyclin D1 gene transcription, p36D1-p34cdk4 complex activation and p105Rb phosphorylation during mitogenic stimulation of G(1)-arrested human breast cancer cells
61. N-terminally myristoylated Ras proteins require palmitoylation or a polybasic domain for plasma membrane localization
62. Co-purification and direct interaction of Ras with caveolin, an integral membrane protein of caveolae microdomains. Detergent-free purification of caveolae microdomains
63. GTP-dependent segregation of H-ras from lipid rafts is required for biological activity
64. Mechanism of estrogen activation of c-Myc oncogene expression
65. Role of MAP kinase in the enhanced cell proliferation of long term estrogen deprived human breast cancer cells
66. Inhibition of mitogen-activated protein kinase and phosphatidylinositol 3-kinase activity in MCF-7 cells prevents estrogen-induced mitogenesis
67. Effects of tyrosine kinase inhibitors on the proliferation of human breast cancer cell lines and proteins important in the ras signaling pathway
68. Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase
69. Nongenomic actions of steroid hormones in reproductive tissues
70. Nongenomic effects of 17β-estradiol on maturing human oocytes: Relationship to oocyte developmental potential
71. A new, nongenomic estrogen action: The rapid release of intracellular calcium
72. Endometrial cell calcium and oestrogen action
73. Effect of estrogen and progesterone treatment on calcium uptake by the myometrium and smooth muscle of the lower urinary tract
74. Estrogen action via the cAMP signaling pathway: Stimulation of adenylate cyclase and cAMP-regulated gene transcription
75. Rapid insulinotropic effect of 17β-estradiol via a plasma membrane receptor
76. Hormonal regulation of CREB phosphorylation in the anteroventral periventricular nucleus
77. Estrogen rapidly induces the phosphorylation of the cAMP response element binding protein in rat brain
78. Antibodies to the estrogen receptor-α modulate rapid prolactin release from rat pituitary tumor cells through plasma membrane estrogen receptors
79. Estradiol coupling to endothelial nitric oxide stimulates gonadotropin-releasing hormone release from rat median eminence via a membrane receptor
80. Nuclear estrogen receptors (ERs) originate from a single transcript: Studies of ER-α and -β expressed in Chinese hamster ovary cells
81. Plasma membrane estrogen receptors signal to antiapoptosis in breast cancer
82. Tyrosine kinase/p21ras/MAP-kinase pathway activation by estradiol-receptor complex in MCF-7 cells
83. Estradiol activation of human colon carcinoma-derived Caco-2 cell growth
84. Potential neuronal mechanisms of estrogen actions in synaptogenesis and synaptic plasticity
85. Estrogen action at endometrial membranes: Alterations in luminal surface detectable within seconds
86. Rapid activation of MAP kinase by estrogen in the bone cell line
87. Rapid membrane effects of steroids in neuroblastoma cells: Effects of estrogen on mitogen-activated protein kinase signalling cascade and c-fos immediate early gene transcription
88. Estrogen-induced activation of mitogen-activated protein kinase in cerebral cortical explants: Convergence of estrogen and neurotrophin signaling pathways
89. Estrogen actions in the central nervous system
90. The mitogen-activated protein kinase pathway mediates estrogen neuroprotection after glutamate toxicity in primary cortical neurons
91. Tyrosine kinase/p21ras/MAP-kinase pathway activation by estradiol-receptor complex in MCF-7 cells
92. Cell membrane and nuclear estrogen receptors (ERs) originate from a single transcript: Studies of ER-α and -β expressed in Chinese hamster ovary cells
93. Estrogen receptor (ER)-α and -β exhibit unique pharmacologic properties when coupled to activation of the mitogen-activated protein kinase pathway
94. Antibodies to the estrogen receptor-α modulate rapid prolactin release from rat pituitary tumor cells through plasma membrane estrogen receptors
95. Estrogen receptor-α detected on the plasma membrane of aldehyde-fixed GH3/B6/F10 rat pituitary tumor cells by enzyme-linked immunocytochemistry
96. Rapid actions of estrogens in GH3/B6 pituitary tumor cells via a plasma membrane version of estrogen receptor-α
97. Metabolic and proliferative responses to estrogen by hepatocytes selected for plasma membrane binding-sites specific for estradiol-17β
98. Non-transcriptional action of oestradiol and progestin triggers DNA synthesis
99. Nongenotropic, sex-nonspecific signaling through the estrogen or androgen receptors: Dissociation from transcriptional activity
100. Activation of the SRC/p21Ras/ERK pathway by progesterone receptor via cross talk with estrogen receptor
101. Convergence of progesterone with growth factor and cytokine signaling in breast cancer. Progesterone receptors regulate signal transducers and activators of transcription expression and activity
102. Specific binding sites for oestrogen at the outer surfaces of isolated endometrial cells
103. α-Shc association and Shc pathway activation
104. Estrogen-induced activation of mitogen-activated protein kinase requires mobilization of intracellular calcium
105. Estrogen-induced activation of ERK-1 and -2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF
106. Elevated mitogen-activated protein kinase activity in estrogen-nonresponsive human breast cancer cells
107. Inhibition of HER2/neu (ERB-B-2) and mitogen-activated protein kinases enhances tamoxifen action against HER2-overexpressing, tamoxifen-resistant breast cancer cells
108. c-ERB-B-2 overexpression decreases the benefit of adjuvant tamoxifen in early-stage breast cancer without axillary lymph node metastases
109. Enhanced epidermal growth factor receptor signaling in MCF-7 breast cancer cells after long-trerm cluture in the presence of the pure antiestrogen ICI 182780 (Faslodex)
110. Estrogen receptor expression and function in long-term estrogen-deprived human breast cancer cells
111. Estradiol hypersensitivity and mitogen-activated protein kinase expression in long-term estrogen deprived human breast cancer cells in vivo
112. Hyperexpression of mitogen-activated protein kinase in human breast cancer
113. Investigation of the MEK-MAP kinase-Rsk pathway in human breast cancer
114. Potential prognostic value of mitogen-activated protein kinase activity for disease-free survival of primary breast cancer patients
115. Ras activation in human breast cancer
116. Altered MAP kinase (ERK-1, -2) regulation in primary cultures of mammary tumor cells: Elevated basal activity and sustained response to EGF
117. Effects of estrogen on apoptotic pathways in human breast cancer cell line MCF-7
118. Hormonal regulation of apoptosis in breast cells and tissues
119. Influence of estrogen, antiestrogen and UV-light on the balance between proliferation and apoptosis in MCF-7 breast adenocarcinoma cells culture
120. Differences in protein kinase C and estrogen receptor α, β expression and signaling correlate with apoptotic sensitivity of MCF-7 breast cancer cell variants
121. 17β-Estradiol inhibits apoptosis in MCF-7 cells, inducing Bcl-2 expression via two estrogen-responsive elements present in the coding sequence
122. Interconnections between E2-dependent regulation of cell cycle progression and apoptosis in MCF-7 tumors growing on nude mice
123. Role of proliferation and apoptosis in net growth rates of human breast cancer cells (MCF-7) treated with oestradiol and/or tamoxifen
124. Effects of environmental estrogens on tumor necrosis factor-α-mediated apoptosis in MCF-7 cells
125. Tamoxifen-induced apoptosis in breast cancer cells relates to down-regulation of Bcl-2, but not bax and Bcl-X(L), without alteration of p53 protein levels